| 25 May 2026 |
CJC-1295 w/o DAC 5mg + IPA 5mg Blend |
5.1 |
20mg |
22.6mg |
+12.9% |
97.06% |
Lab G |
| 25 May 2026 |
Exemestane (Aromasin) Raw |
4.8 |
5g |
4.5g |
-10.1% |
99.26% |
Lab D |
| 25 May 2026 |
P21 |
4.8 |
10mg |
11.1mg |
+11.3% |
96.92% |
Lab A |
| 24 May 2026 |
Chonluten |
4.0 |
2mg |
1.8mg |
-11.1% |
96.56% |
Lab F |
| 24 May 2026 |
Supertest 450 |
4.0 |
100mg/ml |
111.5mg/ml |
+11.5% |
95.55% |
Lab A |
| 24 May 2026 |
Tadalafil Raw |
4.0 |
500g |
533.8g |
+6.8% |
97.50% |
Lab A |
| 24 May 2026 |
GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg |
5.0 |
10mg |
9.7mg |
-2.9% |
96.27% |
Lab C |
| 24 May 2026 |
Methylene Blue |
7.5 |
25mg |
22.1mg |
-11.6% |
97.63% |
Lab A |
| 23 May 2026 |
BPC-157 Arg Oral |
5.6 |
25mg |
28.5mg |
+13.9% |
95.11% |
Lab C |
| 23 May 2026 |
EPO |
6.9 |
5mg |
4.3mg |
-14.0% |
99.67% |
Lab F |
| 23 May 2026 |
CJC-1295 w/o DAC 10mg + IPA 10mg Blend |
4.0 |
30mg |
31.2mg |
+4.1% |
97.34% |
Lab B |
| 23 May 2026 |
Vilon |
5.1 |
2mg |
2.4mg |
+19.6% |
99.18% |
Lab G |
| 21 May 2026 |
Nitroethane CAS 79-24-3 |
7.8 |
1g |
1.2g |
+17.9% |
98.46% |
Lab D |
| 20 May 2026 |
NA Semax Amidate |
6.3 |
2mg |
2.0mg |
-1.1% |
95.21% |
Lab A |
| 19 May 2026 |
BPC-157 Arg Oral |
5.2 |
50mg |
44.0mg |
-11.9% |
98.71% |
Lab G |
| 19 May 2026 |
N-Acetyl Epitalon Amidate |
4.3 |
15mg |
13.2mg |
-12.2% |
98.90% |
Lab C |
| 19 May 2026 |
NAD+ |
4.3 |
10mg |
9.4mg |
-6.4% |
97.90% |
Lab A |
| 17 May 2026 |
17a-Methyl-1-Testosterone |
6.8 |
50mg |
58.6mg |
+17.2% |
96.36% |
Lab G |
| 29 Jan 2026 |
Nitroethane CAS 79-24-3 |
6.4 |
5g |
6.0g |
+20.0% |
99.22% |
Lab F |
| 26 Jan 2026 |
Andarine (S-4) Raw |
6.7 |
5g |
4.4g |
-11.5% |
99.24% |
Lab G |
| 26 Jan 2026 |
NAD+ |
4.0 |
30mg |
26.1mg |
-13.1% |
95.80% |
Lab B |
| 26 Jan 2026 |
P21 |
4.4 |
5mg |
4.5mg |
-9.7% |
97.88% |
Lab G |
| 9 Jan 2026 |
ARA-290 |
6.4 |
50mg |
42.9mg |
-14.3% |
95.55% |
Lab C |
| 7 Jan 2026 |
CJC-1295 w/o DAC 10mg + IPA 10mg Blend |
6.2 |
10mg |
10.9mg |
+9.2% |
98.02% |
Lab F |
| 7 Jan 2026 |
Tirzepatide 30mg Pen Kit |
5.7 |
5mg |
5.9mg |
+18.1% |
98.92% |
Lab F |
| 29 Dec 2025 |
N-Acetyl Epitalon Amidate |
4.3 |
20mg |
23.4mg |
+17.2% |
97.28% |
Lab E |
| 12 Dec 2025 |
CJC-1295 w/o DAC 5mg + IPA 5mg Blend |
6.1 |
10mg |
8.8mg |
-11.8% |
95.79% |
Lab E |
| 12 Dec 2025 |
NA Semax Amidate |
7.3 |
20mg |
24.2mg |
+20.9% |
98.90% |
Lab A |
| 12 Dec 2025 |
Semax |
4.0 |
50mg |
49.2mg |
-1.6% |
98.06% |
Lab A |
| 12 Dec 2025 |
Winstrol (Stanozolol) |
4.7 |
20mg |
18.0mg |
-10.0% |
97.07% |
Lab G |
| 5 Dec 2025 |
Cagrilintide 5mg + Semaglutide 5mg Blend |
4.0 |
20mg |
20.9mg |
+4.6% |
97.97% |
Lab F |
| 14 Nov 2025 |
Exemestane (Aromasin) Raw |
4.3 |
5g |
4.9g |
-2.4% |
95.32% |
Lab G |
| 14 Nov 2025 |
Vilon |
5.3 |
2mg |
2.2mg |
+9.0% |
95.80% |
Lab A |
| 5 Nov 2025 |
GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg |
6.0 |
10mg |
9.7mg |
-3.1% |
97.37% |
Lab G |
| 5 Nov 2025 |
PE 22-28 |
9.8 |
30mg |
31.8mg |
+5.9% |
97.82% |
Lab F |
| 17 Oct 2025 |
1-Boc-4-AP (tert-butyl 4-(phenylamino)piperidine-1-carboxylate) CAS 125541-22-2 |
4.0 |
5g |
5.8g |
+16.7% |
99.12% |
Lab C |
| 17 Oct 2025 |
EPO |
6.9 |
20mg |
18.5mg |
-7.7% |
95.14% |
Lab C |
| 9 Oct 2025 |
Tadalafil Raw |
4.9 |
1g |
1.2g |
+23.5% |
96.47% |
Lab E |
| 3 Oct 2025 |
SNAP-8 |
4.4 |
15mg |
18.6mg |
+24.1% |
95.42% |
Lab B |
| 8 May 2025 |
Melanotan II |
7.0 |
10mg |
9.79mg |
-2.1% |
99.50% |
Lab E |
| 8 May 2025 |
Melanotan II |
2.2 |
10mg |
3.07mg |
-69.3% |
98.81% |
Lab E |
| 7 May 2025 |
Ipamorelin |
5.4 |
5mg |
5.84mg |
+16.8% |
100.00% |
Lab E |
| 7 May 2025 |
Semaglutide |
5.6 |
5mg |
5.05mg |
+1.0% |
98.58% |
Lab E |
| 7 May 2025 |
Retatrutide |
5.0 |
15mg |
14.5mg |
-3.3% |
97.30% |
Lab E |
| 7 May 2025 |
Retatrutide |
5.0 |
15mg |
14.3mg |
-4.7% |
96.45% |
Lab E |
| 7 May 2025 |
Ipamorelin |
6.1 |
5mg |
5.36mg |
+7.2% |
99.43% |
Lab E |